Hunter Capital RTO 1 extends ResoTher Pharma deal talks deadline to Dec. 31, 2026

Bitget2026/09/30 12:45

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Hunter Capital RTO 1 extended its non-binding letter of intent with ResoTher Pharma for a planned reverse acquisition transaction.
The deadline moved to Dec. 31, 2026 from Sept. 30, 2026 to allow time to complete remaining steps.
Key terms of the proposed deal remain unchanged, aside from the revised timetable.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunter Capital RTO 1 AB (publ) published the original content used to generate this news brief via Cision (Ref. ID: 202609300845BITN____UKPR__SV_20260930-BIT-7380-0) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Hunter Capital RTO 1 extends ResoTher Pharma deal talks deadline to Dec. 31, 2026

You may also like

Crypto prices